The Philadelphia chromosome is a genetic change that forms when parts of two separate genes join unexpectedly. When present, it signals a strong likelihood of Chronic Myeloid Leukemia (CML) or a subtype of Acute Lymphoblastic Leukemia (ALL). Rather than guessing, physicians rely on this signal to define the illness clearly. From there, treatment paths become more targeted, shaped by what the BCR test reveals.
Understanding the BCR Test
As a result of a genetic transfer between chromosomes 9 and 22, chromosome 22 becomes noticeably shorter and is widely recognised as the Philadelphia chromosome. Unlike normal proteins, the one produced by this fusion functions without stopping, driving white blood cells into constant replication. Identification of this distinct pattern via a BCR test confirms the presence of leukaemia tied to this mutation.
The Role in Detecting and Monitoring Leukemia
Beginning at diagnosis, this evaluation aids extended care through multiple channels:
- Definitive Diagnosis: Should symptoms like exhaustion or a swollen spleen appear, suspicion might shift toward leukaemia. While elevated white blood cell counts emerge through routine tests, pinpointing the precise form demands detection of genetic markers. Under magnification, rearranged genes reveal themselves when fluorescent probes bind during FISH (Fluorescence In Situ Hybridisation) procedures.
- Treatment Selection: The discovery of the BCR-ABL1 gene altered the approach to treating specific cancers. Drugs like imatinib act directly upon the faulty molecule. However, effectiveness depends entirely on confirmation through testing; treatment does not proceed unless the mutation is proven to exist.
- Tracking Leftover Cancer Cells: Using quantitative PCR, doctors measure circulating BCR-ABL1 gene levels to determine the “molecular load.” This is essential for detecting Minimal Residual Disease (MRD) even when blood looks normal and symptoms are absent.
The Testing Process: How It Is Performed
While the process is simple for the patient, it requires high-precision laboratory equipment.
- Sample Collection: Testing uses either a venous blood draw or a bone marrow aspiration. Doctors typically choose bone marrow for the initial diagnosis to gain full insight, while blood samples are used more frequently for tracking progress.
- Laboratory Analysis: Genetic content is replicated using techniques like Reverse Transcription Polymerase Chain Reaction (RT-PCR). This allows for the accurate measurement of BCR-ABL1 transcripts, growing the signal large enough to quantify.
BCR Test Cost India
With progress in technology, prices for genetic tests in India have shifted downward, though access stays limited to niche providers. Depending on the purpose, costs differ; some assessments detect only if a gene exists; others track precise amounts over time. Throughout India, the price of BCR tests typically ranges from ₹4,500 to ₹10,500.
- Qualitative PCR Testing: A sum of ₹4,500 up to ₹6,000 typically covers this assessment. Payment may differ slightly depending on location or facility. This range remains common across most centres offering the service.
- Quantitative (IS) PCR Testing: A price range of ₹7,000 up to ₹10,500 often applies. This method uses international standards for measurement. At times, costs shift slightly due to lab conditions. Fees may differ across facilities offering the test.
For reliable results and clinical precision, choosing an expert provider like MedGenome ensures your diagnostic journey is supported by leading-edge technology.
Write and Win: Participate in Creative writing Contest & International Essay Contest and win fabulous prizes.
About the Author
